AI Transparency Report
The Amyotrophic Lateral Sclerosis Assn (ALSA) demonstrates a fluctuating but generally strong financial position, with significant revenue spikes, notably in 2015 ($138M) and 2024 ($126M), likely reflecting successful fundraising campaigns such as the Ice Bucket Challenge. The organization's assets have remained robust, consistently above $94 million, indicating a healthy reserve capacity. While specific program, administrative, and fundraising expense breakdowns are not provided in the raw data, the overall expense levels have generally been well-managed relative to revenue, with the exception of a few years where expenses exceeded revenue (e.g., 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016). The consistent reporting of 0% officer compensation in the provided data suggests either that executive compensation is not reported in this specific field or that it is covered under other expense categories, which could impact transparency if not clearly disclosed elsewhere. However, the organization's consistent filing history and substantial asset base point to a well-established and generally stable operation.